Skip to search formSkip to main contentSkip to account menu

BRL-43694A

Known as: BRL43694A, BRL-43694, BRL43694 
National Institutes of Health

Related topics

Related topics

5 relations
7-hydroxygranisetronKytril

Broader (3)

AntiemeticsGranisetronSerotonin Antagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting
SummaryIn a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 μg/kg was given to 24 patients. All… 
1993
1993
Mechanism of motilin-induced contractions in isolated perfused canine stomach.
1992
1992
Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
This report describes the development of novel benzamides which are orally active, highly potent, specific antagonists of 5-HT3… 
1992
1992
Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Two new classes of potent 5-HT3 agents have been developed and examined as inhibitors of cytotoxic drug induced emesis in the… 
1991
1991
Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance
Review
1991
Review
1991
5-HT3 Receptor Antagonists
SummaryThe serotonin (5-hydroxytryptamine, 5-HT) antagonists, which bind at the type 3 receptor (5-HT3 receptor), have been… 
Highly Cited
1990
Highly Cited
1990
Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
1990
1990
Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity
1990
1990
Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
1988
1988
Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930
Summary1.The binding characteristics of [3H]ICS 205-930, a potent and selective 5-hydroxytryptamine 5-HT3 receptor antagonist… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)